Advertisement

Index by Author

September 1998; 47 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abel, E D

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  2. Ahrén, B

    • Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol. Diabetes September 1998 47:1436-1443; doi:10.2337/diabetes.47.9.1436

  3. Aiello, L P

    • Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes September 1998 47:1480-1488; doi:10.2337/diabetes.47.9.1480

  4. Ashcroft, F M

    • Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes September 1998 47:1412-1418; doi:10.2337/diabetes.47.9.1412

B

  1. Bain, S C

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

  2. Baqué, S

    • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes September 1998 47:1392-1398; doi:10.2337/diabetes.47.9.1392

  3. Bennett, P H

    • Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians. Diabetes September 1998 47:1489-1493; doi:10.2337/diabetes.47.9.1489

  4. Bhagroo, N V

    • Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes September 1998 47:1426-1435; doi:10.2337/diabetes.47.9.1426

  5. Bogardus, C

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  6. Brelje, T C

    • Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes September 1998 47:1426-1435; doi:10.2337/diabetes.47.9.1426

  7. Byrne, C D

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

C

  1. Chaturvedi, N

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  2. Chen, C

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  3. Cohen, P T

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  4. Cotroneo, P

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  5. Craft, S

    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

  6. Cryer, P E

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444
    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

  7. Cucca, F

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

D

  1. Dence, C S

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444

  2. Digby, J

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384
    • Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes September 1998 47:1528-1531; doi:10.2337/diabetes.47.9.1528

  3. Dussoix, P

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

E

  1. Efrat, S

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  2. Elliott, J F

    • Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes September 1998 47:1406-1411; doi:10.2337/diabetes.47.9.1406

  3. Esposito, L

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

F

  1. Fanelli, C G

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444
    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

  2. Fischer, J W

    • Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes September 1998 47:1512-1518; doi:10.2337/diabetes.47.9.1512

  3. Fleischer, N

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  4. Froguel, P

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  5. Fukuda, M

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  6. Fuller, J H

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

G

  1. Gammeltoft, S

    • Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes September 1998 47:1451-1458; doi:10.2337/diabetes.47.9.1451

  2. Giachelli, C M

    • Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes September 1998 47:1512-1518; doi:10.2337/diabetes.47.9.1512

  3. Gómez-Foix, A M

    • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes September 1998 47:1392-1398; doi:10.2337/diabetes.47.9.1392

  4. Goy, J V

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

  5. Gribble, F M

    • Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes September 1998 47:1412-1418; doi:10.2337/diabetes.47.9.1412

  6. Grujic, D

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  7. Guenat, E

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  8. Guinovart, J J

    • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes September 1998 47:1392-1398; doi:10.2337/diabetes.47.9.1392

H

  1. Han, W

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  2. Harper, M E

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  3. Hershey, T

    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

  4. Himms-Hagen, J

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  5. Hotta, F

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

I

  1. Ishii, T

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  2. Ishizawa, M

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  3. Ishizuka, T

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  4. Itaya, S

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  5. Ito, M

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  6. Ito, T

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

J

  1. Jéquier, E

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

K

  1. Kahn, C R

    • Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes September 1998 47:1451-1458; doi:10.2337/diabetes.47.9.1451

  2. Kajita, K

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  3. Kanoh, Y

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  4. Karlsson, S

    • Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol. Diabetes September 1998 47:1436-1443; doi:10.2337/diabetes.47.9.1436

  5. Kigoshi, T

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  6. Kimura, M

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  7. King, G L

    • Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes September 1998 47:1480-1488; doi:10.2337/diabetes.47.9.1480

  8. Kitazawa, M

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  9. Knowler, W C

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  10. Korbutt, G S

    • Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes September 1998 47:1406-1411; doi:10.2337/diabetes.47.9.1406

  11. Krook, A

    • Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes September 1998 47:1528-1531; doi:10.2337/diabetes.47.9.1528

L

  1. Lawitts, J

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  2. Leiser, M

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  3. Lowell, B B

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  4. Luong, L A

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

M

  1. Maguire, J

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  2. Majer, M

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  3. Mandel, T E

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  4. Manto, A

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  5. Maratos-Flier, E

    • Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes September 1998 47:1451-1458; doi:10.2337/diabetes.47.9.1451

  6. Markham, J

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444

  7. Merriman, M E

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

  8. Miura, A

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  9. Montague, C T

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

  10. Montell, E

    • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes September 1998 47:1392-1398; doi:10.2337/diabetes.47.9.1392

  11. Morgenstern, H

    • Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians. Diabetes September 1998 47:1489-1493; doi:10.2337/diabetes.47.9.1489

  12. Mottram, P L

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  13. Murray-Segal, L J

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  14. Muto, N

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

N

  1. Nakano, S

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  2. Nannipieri, M

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  3. Nelson, R G

    • Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians. Diabetes September 1998 47:1489-1493; doi:10.2337/diabetes.47.9.1489

  4. Newgard, C B

    • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes September 1998 47:1392-1398; doi:10.2337/diabetes.47.9.1392

  5. Nishizawa, M

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  6. Norman, R A

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

O

  1. O'Rahilly, S

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384
    • Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes September 1998 47:1528-1531; doi:10.2337/diabetes.47.9.1528

  2. Ovalle, F

    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

P

  1. Paramore, D S

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444
    • Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes September 1998 47:1472-1479; doi:10.2337/diabetes.47.9.1472

  2. Penno, G

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  3. Philippe, J

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  4. Piper, M

    • Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes September 1998 47:1451-1458; doi:10.2337/diabetes.47.9.1451

  5. Powers, W J

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444

  6. Pralong, W

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  7. Prins, J B

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

  8. Prochazka, M

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

R

  1. Rajotte, R V

    • Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes September 1998 47:1406-1411; doi:10.2337/diabetes.47.9.1406

  2. Rayat, G R

    • Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes September 1998 47:1406-1411; doi:10.2337/diabetes.47.9.1406

  3. Reed, P W

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

  4. Reinecke, A

    • Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes September 1998 47:1512-1518; doi:10.2337/diabetes.47.9.1512

  5. Robertson, R P

    • Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes September 1998 47:1379-1383; doi:10.2337/diabetes.47.9.1379

  6. Rossetti, L

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

S

  1. Sanders, L

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

  2. Scherer, S W

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  3. Schneiter, P

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  4. Seino, S

    • Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes September 1998 47:1412-1418; doi:10.2337/diabetes.47.9.1412

  5. Sewter, C P

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

  6. Simonsson, E

    • Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol. Diabetes September 1998 47:1436-1443; doi:10.2337/diabetes.47.9.1436

  7. Sorenson, R L

    • Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes September 1998 47:1426-1435; doi:10.2337/diabetes.47.9.1426

  8. Stein-Oakley, A

    • Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes September 1998 47:1399-1405; doi:10.2337/diabetes.47.9.1399

  9. Strosberg, A D

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  10. Surana, M

    • Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes September 1998 47:1419-1425; doi:10.2337/diabetes.47.9.1419

  11. Surmely, J F

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  12. Susulic, V S

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

T

  1. Takagi, H

    • Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes September 1998 47:1480-1488; doi:10.2337/diabetes.47.9.1480

  2. Talmud, P J

    • Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes September 1998 47:1507-1511; doi:10.2337/diabetes.47.9.1507

  3. Tappy, L

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  4. Temler, E

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  5. Todd, J A

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

  6. Tschöpe, C

    • Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes September 1998 47:1512-1518; doi:10.2337/diabetes.47.9.1512

  7. Tucker, S J

    • Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes September 1998 47:1412-1418; doi:10.2337/diabetes.47.9.1412

U

  1. Uchida, K

    • Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes September 1998 47:1501-1506; doi:10.2337/diabetes.47.9.1501

  2. Unger, T

    • Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes September 1998 47:1512-1518; doi:10.2337/diabetes.47.9.1512

V

  1. Vaxillaire, M

    • Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes September 1998 47:1459-1463; doi:10.2337/diabetes.47.9.1459

  2. Vicent, D

    • Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes September 1998 47:1451-1458; doi:10.2337/diabetes.47.9.1451

  3. Vidal-Puig, A

    • Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes September 1998 47:1464-1471; doi:10.2337/diabetes.47.9.1464

  4. Videen, T O

    • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes September 1998 47:1444-1450; doi:10.2337/diabetes.47.9.1444

W

  1. Wada, H

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

  2. Wallberg-Henriksson, H

    • Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes September 1998 47:1528-1531; doi:10.2337/diabetes.47.9.1528

  3. Weinhaus, A J

    • Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes September 1998 47:1426-1435; doi:10.2337/diabetes.47.9.1426

  4. Wilson, A J

    • Investigation of linkage of chromosome 8 to type 1 diabetes: multipoint analysis and exclusion mapping of human chromosome 8 in 593 affected sib-pair families from the U.K. and U.S. Diabetes September 1998 47:1525-1527; doi:10.2337/diabetes.47.9.1525

X

  1. Xia, J

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

  2. Xi, T

    • A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes September 1998 47:1519-1524; doi:10.2337/diabetes.47.9.1519

Y

  1. Yasuda, K

    • Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Diabetes September 1998 47:1494-1500; doi:10.2337/diabetes.47.9.1494

Z

  1. Zhang, J

    • Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes September 1998 47:1384-1391; doi:10.2337/diabetes.47.9.1384

  2. Zierath, J R

    • Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes September 1998 47:1528-1531; doi:10.2337/diabetes.47.9.1528

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement